Biologic Therapies for Severe Asthma

被引：318
|
作者：
Brusselle, Guy G. [1 ,2 ]
Koppelman, Gerard H. [3 ,4 ]
机构：
[1] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium
[2] Erasmus MC, Dept Epidemiol & Resp Med, Rotterdam, Netherlands
[3] Univ Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp, Univ Med Ctr Groningen, Groningen, Netherlands
[4] Univ Groningen, Groningen Res Inst Asthma & COPD, Univ Med Ctr Groningen, Groningen, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 386卷 / 02期
关键词：
SEVERE EOSINOPHILIC ASTHMA; QUALITY-OF-LIFE; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; PRECISION MEDICINE; NASAL POLYPOSIS; MEPOLIZUMAB; PLACEBO; BENRALIZUMAB; EFFICACY;
D O I：
10.1056/NEJMra2032506
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Biologic Therapies for Severe Asthma Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may be required to reduce the disease burden. This review discusses the mechanisms, efficacy, and safety of biologics for severe asthma.
引用
收藏
页码：157 / 171
页数：15
相关论文
共 50 条
  • [41] Traditional Therapies for Severe Asthma
    Wang, Eileen
    Hoyte, Flavia C. L.
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2016, 36 (03) : 581 - +
  • [42] Emerging therapies for severe asthma
    Thomson, Neil C.
    Chaudhuri, Rekha
    Spears, Mark
    [J]. BMC MEDICINE, 2011, 9
  • [43] Emerging therapies for severe asthma
    Neil C Thomson
    Rekha Chaudhuri
    Mark Spears
    [J]. BMC Medicine, 9
  • [44] Biologic therapies for moderate to severe hidradenitis suppurativa
    Consuegra Romero, Germana
    Lacalle Calderon, Marina
    Vilanova Urdaniz, Iosune
    Blanco Alonso, Ricardo
    Castro Gutierrez, Beatriz
    Gonzalez Vela, Carmen
    Lopez Obregon, Cristina
    Fernandez Llaca, Hector
    Gonzalez Lopez, Marcos
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB45 - AB45
  • [45] Biologic Therapies for Moderate to Severe Psoriasis Are Not Interchangeable
    Puig, L.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2014, 105 (05): : 483 - 486
  • [46] Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
    Jackson, David J.
    Busby, John
    Pfeffer, Paul E.
    Menzies-Gow, Andrew
    Brown, Thomas
    Gore, Robin
    Doherty, Martin
    Mansur, Adel H.
    Message, Simon
    Niven, Robert
    Patel, Mitesh
    Heaney, Liam G.
    [J]. THORAX, 2021, 76 (03) : 220 - 227
  • [47] Eligibility for Newer Biologic Therapies in Severe Asthma, Re-analysis of the Identification and Description of sEvere Asthma patients in a cross-sectionaL (IDEAL) Study
    Hinds, D.
    Gibbons, D.
    Gunsoy, N. B.
    Stott-Miller, M.
    Albers, F. C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [48] The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma
    Nanzer, Alexandra M.
    Taylor, Victoria
    Hearn, Andrew P.
    Kavanagh, Joanne E.
    Patrick, Tanya
    Green, Linda
    Thomson, Louise
    Lam, Jodie
    Fernandes, Mariana
    Roxas, Cris
    d'Ancona, Grainne
    Kent, Brian D.
    Dhariwal, Jaideep
    Jackson, David J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (02)
  • [49] Factors to Consider in Prescribing Asthma Biologic Therapies to Children
    Anderson, William C., III
    Banzon, Tina M.
    Chawes, Bo
    Papadopoulos, Nikolaos G.
    Phipatanakul, Wanda
    Szefler, Stanley J.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (03): : 693 - 701
  • [50] The Current State of Biologic Therapies for Treatment of Refractory Asthma
    Matthew Mavissakalian
    Sean Brady
    [J]. Clinical Reviews in Allergy & Immunology, 2020, 59 : 195 - 207
12345